0R0H Stock Overview
Thermo Fisher Scientific Inc. provides life sciences solutions, analytical instruments, specialty diagnostics, and laboratory products and biopharma services in the North America, Europe, Asia-Pacific, and internationally.
| Snowflake Score | |
|---|---|
| Valuation | 1/6 |
| Future Growth | 2/6 |
| Past Performance | 3/6 |
| Financial Health | 3/6 |
| Dividends | 0/6 |
Thermo Fisher Scientific Inc. Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | US$573.08 |
| 52 Week High | US$603.14 |
| 52 Week Low | US$416.66 |
| Beta | 0.80 |
| 1 Month Change | -0.62% |
| 3 Month Change | 4.20% |
| 1 Year Change | 2.93% |
| 3 Year Change | 21.49% |
| 5 Year Change | 106.29% |
| Change since IPO | 160.75% |
Recent News & Updates
Recent updates
Shareholder Returns
| 0R0H | GB Life Sciences | GB Market | |
|---|---|---|---|
| 7D | 5.2% | -1.1% | 2.2% |
| 1Y | 2.9% | -46.8% | 0.9% |
Return vs Industry: 0R0H exceeded the UK Life Sciences industry which returned -46.8% over the past year.
Return vs Market: 0R0H exceeded the UK Market which returned 0.9% over the past year.
Price Volatility
| 0R0H volatility | |
|---|---|
| 0R0H Average Weekly Movement | 2.8% |
| Life Sciences Industry Average Movement | 7.8% |
| Market Average Movement | 4.8% |
| 10% most volatile stocks in GB Market | 11.3% |
| 10% least volatile stocks in GB Market | 2.7% |
Stable Share Price: 0R0H has not had significant price volatility in the past 3 months.
Volatility Over Time: 0R0H's weekly volatility (3%) has been stable over the past year.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 1956 | 122,000 | Marc Casper | www.thermofisher.com |
Thermo Fisher Scientific Inc. provides life sciences solutions, analytical instruments, specialty diagnostics, and laboratory products and biopharma services in the North America, Europe, Asia-Pacific, and internationally. The company’s Life Sciences Solutions segment offers reagents, instruments, and consumables for biological and medical research, discovery, and production of drugs and vaccines, as well as diagnosis of infections and diseases; and solutions include biosciences, genetic sciences, and bio production to pharmaceutical, biotechnology, agricultural, clinical, healthcare, academic, and government markets. Its Analytical Instruments segment provides instruments, consumables, software, and services for pharmaceutical, biotechnology, academic, government, environmental, and other research and industrial markets, as well as clinical laboratories.
Thermo Fisher Scientific Inc. Fundamentals Summary
| 0R0H fundamental statistics | |
|---|---|
| Market cap | US$218.24b |
| Earnings (TTM) | US$6.03b |
| Revenue (TTM) | US$42.49b |
36.3x
P/E Ratio5.2x
P/S RatioIs 0R0H overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| 0R0H income statement (TTM) | |
|---|---|
| Revenue | US$42.49b |
| Cost of Revenue | US$25.37b |
| Gross Profit | US$17.12b |
| Other Expenses | US$11.09b |
| Earnings | US$6.03b |
Last Reported Earnings
Mar 30, 2024
Next Earnings Date
n/a
| Earnings per share (EPS) | 15.81 |
| Gross Margin | 40.29% |
| Net Profit Margin | 14.20% |
| Debt/Equity Ratio | 78.0% |
How did 0R0H perform over the long term?
See historical performance and comparison